Takeshita Yukio
Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine.
Brain Nerve. 2021 May;73(5):511-515. doi: 10.11477/mf.1416201793.
Primary central nervous system (CNS) vasculitis is an uncommon disorder of unknown etiology that is restricted to the brain and spinal cord. Patients do not present with specific clinical features or a classical clinical course, and no blood or imaging investigations are available for diagnostic confirmation. Cerebral biopsy and angiography are the gold standards for diagnosis. No randomized clinical trials have described a therapeutic regimen effective for primary CNS vasculitis; therefore, treatment of primary CNS vasculitis is based on therapeutic strategies used for other types of vasculitis. Early diagnosis is important because corticosteroid-based treatment with or without concomitant cyclophosphamide administration can often prevent serious outcomes and may be followed by a favorable response. Several immunosuppressants such as mycophenolate mofetil, tumor necrosis factor-α blockers, and rituximab may be useful options for patients refractory to the aforementioned regimen. We describe some diagnostic and therapeutic approaches for the management of this condition, with a focus on the importance of obtaining tissue and angiographic evaluation (formal contrast-enhanced or magnetic resonance/computed tomography angiography).
原发性中枢神经系统(CNS)血管炎是一种病因不明的罕见疾病,仅限于脑和脊髓。患者没有特定的临床特征或典型的临床病程,也没有血液或影像学检查可用于确诊。脑活检和血管造影是诊断的金标准。尚无随机临床试验描述对原发性CNS血管炎有效的治疗方案;因此,原发性CNS血管炎的治疗基于用于其他类型血管炎的治疗策略。早期诊断很重要,因为基于皮质类固醇的治疗(联合或不联合环磷酰胺给药)通常可以预防严重后果,并且可能会有良好的反应。几种免疫抑制剂,如霉酚酸酯、肿瘤坏死因子-α阻滞剂和利妥昔单抗,可能是对上述治疗方案难治的患者的有用选择。我们描述了一些用于管理这种疾病的诊断和治疗方法,重点是获取组织和血管造影评估(正式的对比增强或磁共振/计算机断层血管造影)的重要性。